LianBio SEC filings LIANY

LianBio has 170 filings in SEC EDGAR's recent list, going back to Nov 12, 2020. Its latest annual report, Form 10-K, was filed on Mar 28, 2023 for the period ended Dec 31, 2022. The latest quarterly report (Form 10-Q) was filed on Nov 13, 2023, covering the quarter ended Sep 30, 2023. The most recent current report (Form 8-K) was filed on Feb 13, 2024 (exit or restructuring costs, listing notice, regulation fd disclosure, other events). The company's fiscal year ends on December 31.

LianBio SEC filings
Form Description Filed Period
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
4 Insider transaction Apr 11, 2024 Jan 2, 2024
15-12G Deregistration Mar 21, 2024 —
EFFECT Filing Mar 12, 2024 —
F-6 POS Filing Mar 12, 2024 —
S-8 POS Filing Mar 12, 2024 —
S-8 POS Filing Mar 12, 2024 —
S-8 POS Filing Mar 12, 2024 —
POS AM Filing Mar 12, 2024 —
25 Filing Mar 11, 2024 —
SC 13D/A Amended ownership over 5% (active) Feb 29, 2024 —
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
8-K Current report
Exit or restructuring costs, Listing notice, Regulation FD disclosure, Other events
Feb 13, 2024 Feb 9, 2024
144 Notice of proposed sale Jan 8, 2024 —
144 Notice of proposed sale Dec 29, 2023 —
3 Initial insider ownership Dec 26, 2023 Dec 19, 2023
8-K Current report
Material agreement, Agreement ended
Dec 26, 2023 Dec 22, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 20, 2023 Dec 19, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 19, 2023 Dec 16, 2023
8-K Current report
Regulation FD disclosure
Dec 6, 2023 Dec 6, 2023
8-K Current report
Other events
Dec 1, 2023 Nov 30, 2023
SC 13D Ownership over 5% (active) Nov 30, 2023 —
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
SC 13G Ownership over 5% (passive) Nov 1, 2023 —
8-K Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Regulation FD disclosure
Oct 30, 2023 Oct 24, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 14, 2023 Aug 14, 2023
UPLOAD Letter from the SEC Jul 24, 2023 —
CORRESP Letter to the SEC Jul 20, 2023 —
UPLOAD Letter from the SEC Jul 10, 2023 —
4 Insider transaction Jun 23, 2023 Jun 21, 2023
4 Insider transaction Jun 23, 2023 Jun 21, 2023
4 Insider transaction Jun 23, 2023 Jun 21, 2023
8-K Current report
Shareholder vote results
Jun 23, 2023 Jun 21, 2023
4 Insider transaction Jun 23, 2023 Jun 21, 2023
4 Insider transaction Jun 23, 2023 Jun 21, 2023
4 Insider transaction Jun 23, 2023 Jun 21, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
8-K Current report
Regulation FD disclosure
May 1, 2023 May 1, 2023
EFFECT Filing Apr 27, 2023 —
CORRESP Letter to the SEC Apr 26, 2023 —
S-3/A Filing Apr 26, 2023 —
8-K Current report
Regulation FD disclosure, Other events
Apr 26, 2023 Apr 26, 2023
8-K Current report
Other events
Apr 21, 2023 Apr 21, 2023
DEFA14A Additional proxy material Apr 19, 2023 —
DEF 14A Proxy statement Apr 19, 2023 Jun 21, 2023
4 Insider transaction Mar 31, 2023 Mar 29, 2023
4 Insider transaction Mar 31, 2023 Mar 29, 2023
4 Insider transaction Mar 31, 2023 Mar 29, 2023
4 Insider transaction Mar 31, 2023 Mar 29, 2023
S-3/A Filing Mar 29, 2023 —
CORRESP Letter to the SEC Mar 28, 2023 —
S-8 Employee stock plan registration Mar 28, 2023 —
10-K Annual report Mar 28, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 27, 2023 Mar 27, 2023
8-K Current report
Officer or director change
Mar 17, 2023 Mar 14, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
4 Insider transaction Jan 24, 2023 Jan 20, 2023
4 Insider transaction Jan 24, 2023 Jan 20, 2023
4 Insider transaction Jan 24, 2023 Jan 20, 2023
4 Insider transaction Jan 24, 2023 Jan 20, 2023
4 Insider transaction Jan 5, 2023 Jan 3, 2023
UPLOAD Letter from the SEC Dec 22, 2022 —
8-K Current report
Material agreement, Regulation FD disclosure
Dec 19, 2022 Dec 16, 2022
8-K Current report
Officer or director change
Dec 13, 2022 Dec 9, 2022
CORRESP Letter to the SEC Dec 9, 2022 —
S-3/A Filing Dec 9, 2022 —
UPLOAD Letter from the SEC Nov 28, 2022 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2022 —
S-3 Shelf registration Nov 10, 2022 —
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 10, 2022 Nov 10, 2022
8-K Current report
Other events
Oct 12, 2022 Oct 12, 2022
4 Insider transaction Aug 22, 2022 Aug 18, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
4 Insider transaction Jun 27, 2022 Jun 23, 2022
4 Insider transaction Jun 27, 2022 Jun 23, 2022
4 Insider transaction Jun 27, 2022 Jun 23, 2022
4 Insider transaction Jun 27, 2022 Jun 23, 2022
4 Insider transaction Jun 27, 2022 Jun 23, 2022
8-K Current report
Shareholder vote results
Jun 10, 2022 Jun 8, 2022
4 Insider transaction May 27, 2022 May 26, 2022
4 Insider transaction May 25, 2022 May 23, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Results of operations, Regulation FD disclosure
May 12, 2022 May 12, 2022
4 Insider transaction May 6, 2022 May 4, 2022
DEFA14A Additional proxy material Apr 28, 2022 —
DEFR14A Filing Apr 28, 2022 —
DEFA14A Additional proxy material Apr 27, 2022 —
DEF 14A Proxy statement Apr 27, 2022 Jun 8, 2022
4 Insider transaction Apr 8, 2022 Apr 6, 2022
3 Initial insider ownership Apr 8, 2022 Apr 6, 2022
8-K Current report
Officer or director change
Apr 8, 2022 Apr 6, 2022
S-8 Employee stock plan registration Mar 31, 2022 —
10-K Annual report Mar 31, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 30, 2022 Mar 30, 2022
8-K Current report
Regulation FD disclosure
Mar 2, 2022 Mar 2, 2022
10-Q/A Amended quarterly report Jan 10, 2022 Sep 30, 2021
4 Insider transaction Jan 3, 2022 Dec 29, 2021
4 Insider transaction Jan 3, 2022 Dec 31, 2021
10-Q Quarterly report Dec 9, 2021 Sep 30, 2021
8-K Current report
Results of operations
Dec 9, 2021 Dec 9, 2021
4 Insider transaction Dec 3, 2021 Dec 1, 2021
SC 13D Ownership over 5% (active) Nov 15, 2021 —
SC 13G Ownership over 5% (passive) Nov 15, 2021 —
8-K Current report
Material agreement, New debt
Nov 10, 2021 Nov 4, 2021
SC 13G Ownership over 5% (passive) Nov 10, 2021 —
3/A Form 3/a submission Nov 9, 2021 Oct 29, 2021
4 Insider transaction Nov 5, 2021 Nov 3, 2021
SEC STAFF LETTER Filing Nov 3, 2021 —
4 Insider transaction Nov 3, 2021 Nov 1, 2021
S-8 Employee stock plan registration Nov 3, 2021 —
8-K Current report
Bylaw or fiscal year change
Nov 3, 2021 Nov 3, 2021
424B4 Prospectus Nov 2, 2021 —
4 Insider transaction Nov 1, 2021 Oct 31, 2021
4 Insider transaction Nov 1, 2021 Oct 31, 2021
4 Insider transaction Nov 1, 2021 Oct 31, 2021
4 Insider transaction Nov 1, 2021 Oct 31, 2021
4 Insider transaction Nov 1, 2021 Oct 31, 2021
4 Insider transaction Nov 1, 2021 Oct 31, 2021
EFFECT Filing Oct 29, 2021 —
EFFECT Filing Oct 29, 2021 —
3 Initial insider ownership Oct 29, 2021 Oct 29, 2021
3 Initial insider ownership Oct 29, 2021 Oct 29, 2021
3 Initial insider ownership Oct 29, 2021 Oct 29, 2021
3 Initial insider ownership Oct 29, 2021 Oct 29, 2021
3 Initial insider ownership Oct 29, 2021 Oct 29, 2021
3 Initial insider ownership Oct 29, 2021 Oct 29, 2021
3 Initial insider ownership Oct 29, 2021 Oct 29, 2021
3 Initial insider ownership Oct 29, 2021 Oct 29, 2021
3 Initial insider ownership Oct 29, 2021 Oct 29, 2021
3 Initial insider ownership Oct 29, 2021 Oct 29, 2021
3 Initial insider ownership Oct 29, 2021 Oct 29, 2021
3 Initial insider ownership Oct 29, 2021 Oct 29, 2021
S-1/A Amended registration statement Oct 29, 2021 —
S-1/A Amended registration statement Oct 27, 2021 —
CORRESP Letter to the SEC Oct 26, 2021 —
F-6/A Filing Oct 26, 2021 —
UPLOAD Letter from the SEC Oct 26, 2021 —
CORRESP Letter to the SEC Oct 25, 2021 —
CORRESP Letter to the SEC Oct 25, 2021 —
CERT Filing Oct 21, 2021 —
8-A12B Filing Oct 20, 2021 —
S-1/A Amended registration statement Oct 20, 2021 —
CORRESP Letter to the SEC Oct 8, 2021 —
S-1/A Amended registration statement Oct 8, 2021 —
F-6 Filing Oct 8, 2021 —
CORRESP Letter to the SEC Oct 7, 2021 —
UPLOAD Letter from the SEC Oct 4, 2021 —
S-1 Registration statement Oct 1, 2021 —
DRSLTR Filing Sep 21, 2021 —
DRS/A Filing Sep 21, 2021 —
UPLOAD Letter from the SEC Sep 14, 2021 —
DRS/A Filing Sep 2, 2021 —
DRSLTR Filing Sep 1, 2021 —
UPLOAD Letter from the SEC Aug 19, 2021 —
DRSLTR Filing Aug 9, 2021 —
DRS/A Filing Aug 9, 2021 —
SEC STAFF LETTER Filing Aug 3, 2021 —
UPLOAD Letter from the SEC Jul 26, 2021 —
DRS Filing Jun 28, 2021 —
D Filing Apr 5, 2021 —
D Filing Nov 12, 2020 —

Showing 170 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LIANY (OTC)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
Princeton, NJ
SEC filer status
, Emerging growth company
SEC CIK
1831283

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.